List

Fact Sheet: President Donald J. Trump Realigns U.S. Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

Fact sheetPublished 05/29Open the original

Summary

President Trump recognizes an HHS scientific assessment of childhood vaccines as a guiding resource and directs the CDC and its Advisory Committee on Immunization Practices to review it and update the childhood and adolescent vaccine schedule.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/05/280.0%0.0%
26/05/29−0.9%+0.1%
26/06/01−2.4%+0.2%
26/06/02−3.0%+0.6%
26/06/03−2.5%−0.6%
26/06/04+0.5%+0.1%
26/06/05+1.9%−2.6%
26/06/08+1.4%−2.2%
26/06/09+2.5%−2.5%
26/06/10+1.9%−4.1%
26/06/11+3.1%−2.1%
26/06/12+3.4%−1.7%
26/06/15+2.4%−0.2%
26/06/16+2.4%−0.6%
26/06/17+1.3%−1.6%
26/06/18−0.5%−1.0%
26/06/22+0.7%−1.5%
26/06/23+2.2%−2.8%
26/06/24+2.2%−2.4%
26/06/25+3.4%−2.8%
26/06/26+5.7%−3.2%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Dermot Mark Durcan

    BuyCencora

    $1.1M

    Filed 06/22

  • Dermot Mark Durcan

    BuyCencora

    $1.1M

    Filed 05/28

  • Lauren M. Tyler

    BuyCencora

    $148.6K

    Filed 06/24

  • Lilly Endowment

    SellELI Lilly

    $13.6M

    Filed 05/07

  • Larry Robbins

    SellCVS Health

    $187.3M

    Filed 05/21

  • Larry Robbins

    SellCVS Health

    $74.6M

    Filed 05/21

  • Larry Robbins

    SellCVS Health

    $34.6M

    Filed 05/21

  • John Boozman

    BuyUnitedhealth Group

    $1K–$15K

    Reported 07/13

  • Kathryn E. Wengel

    SellJohnson & Johnson

    $2.4M

    Filed 06/12

  • Lilly Endowment

    SellELI Lilly

    $2.2M

    Filed 05/07

  • Larry Robbins

    SellCVS Health

    $14.5M

    Filed 05/21

  • Daniel Patrick O'Day

    Sell10b5-1 planGilead Sciences

    $1.4M

    Filed 06/02

  • David Cordani

    Sell10b5-1 planCigna Group

    $11.9M

    Filed 05/14

  • David Cordani

    Sell10b5-1 planCigna Group

    $11.4M

    Filed 05/14

  • Tommy Tuberville

    Full salePfizer

    $15K–$50K

    Reported 07/16

  • David Cordani

    Sell10b5-1 planCigna Group

    $10.3M

    Filed 05/14

  • Brian S. Tyler

    Sell10b5-1 planMcKesson

    $6.6M

    Filed 06/18

  • Larry Robbins

    SellCVS Health

    $6.4M

    Filed 05/21

  • Tilak Mandadi

    SellCVS Health

    $6.2M

    Filed 05/11

  • David Cordani

    Sell10b5-1 planCigna Group

    $4.6M

    Filed 05/14